Flu, cancer, HIV: after Covid success, what next for mRNA vaccines?

The technology was viewed with scepticism before the pandemic but there is now growing confidence about its use

It is one of the most remarkable success stories of the pandemic: the unproven technology that delivered the Moderna and Pfizer/BioNTech vaccines in record time, helping to turn the tide on Covid-19. The vaccines are based on mRNA, the molecule that instructs our cells to make specific proteins. By injecting synthetic mRNA, our cells are turned into on-demand vaccine factories, pumping out any protein we want our immune system to learn to recognise and destroy.

Pre-pandemic, the technology was viewed with scepticism – a clever concept, but not guaranteed to deliver. Now there is growing confidence that mRNA vaccines could have far-reaching applications in tackling diseases from flu to malaria.

Continue reading...

How biodiversity loss is jeopardising the drugs of the future

From willow bark to mosquitoes, nature has been a source of vital medications for centuries. But species die-off caused by human activity is putting this at risk

What will biodiversity loss mean for drug discovery?
Traditionally used as a painkiller for headaches, snowdrops are now known to slow the onset of dementia. In the 1950s, a natural alkaloid called galantamine was extracted from the bulbs. Today, a synthesised version of this is used to treat Alzheimer’s disease and scientists are investigating further to see if snowdrops might also be effective in the treatment of HIV.

However, over-harvesting has resulted in many snowdrop species becoming threatened. The snowdrop isn’t alone – plants are an abundant source of potential new medicines, often providing us with chemical templates for the design of novel drugs. Yet scientists across the globe say unsustainable use of wild medicinal plants is contributing to biodiversity loss and could limit opportunities to source medicines from nature in the future.

Continue reading...

WHO endorses use of world’s first malaria vaccine in Africa

World Health Organization’s director general hails ‘historic day’ in fight against parasitic disease

The World Health Organization has recommended the widespread rollout of the first malaria vaccine, in a move experts hope could save tens of thousands of children’s lives each year across Africa.

Hailing “an historic day”, the WHO’s director general, Dr Tedros Adhanom Ghebreyesus, said that after a successful pilot programme in three African countries the RTS,S vaccine should be made available more widely.

Continue reading...

Malaria trial shows ‘striking’ 70% reduction in severe illness in children

A study in Burkina Faso and Mali suggests combining anti-malarial drugs and vaccination could reduce deaths and hospitalisations

A trial combining vaccinations and prevention drugs has substantially lowered the number of children dying of malaria in two African countries, according to researchers.

The results of the study, published in the New England Journal of Medicine, have been hailed as “very striking”, especially at a time when decades-long progress on combating malaria has stalled in some countries.

Continue reading...

Genetic engineering test with mosquitoes ‘may be game changer’ in eliminating malaria

UK scientist says gene-drive study rendering female insects infertile may lead to ‘self destruct mosquito’ field tests within 10 years

Scientists have successfully wiped out a population of malaria-transmitting mosquitoes by using a radical form of genetic engineering to render the females infertile – in the most advanced and largest ever test of use of the technology to fight the disease.

As well as bringing fresh hope in the fight against one of the world’s biggest killers, the study lays the foundations for further trials of gene-drive technology, which could mean self-destroying mosquitoes being released into the wild within 10 years.

Continue reading...

Climate crisis ‘may put 8bn at risk of malaria and dengue’

Reducing global heating could save millions of people from mosquito-borne diseases, study finds

More than 8 billion people could be at risk of malaria and dengue fever by 2080 if greenhouse gas emissions continue to rise unabated, a new study says.

Malaria and dengue fever will spread to reach billions of people, according to new projections.

Continue reading...

Oxford Malaria vaccine proves highly effective in Burkina Faso trial

Vaccine developed by scientists at Jenner Institute, Oxford, shows up to 77% efficacy in trial over 12 months

A vaccine against malaria has been shown to be highly effective in trials in Africa, holding out the real possibility of slashing the death toll of a disease that kills 400,000 mostly small children every year.

The vaccine, developed by scientists at the Jenner Institute of Oxford University, showed up to 77% efficacy in a trial of 450 children in Burkina Faso over 12 months.

Continue reading...

Scientists sound warning note over malaria drug resistance in Africa

Rwanda study raises fears erosion of efficacy may have begun, with children at greatest risk

Resistance to malaria drugs in Africa may be starting to take hold, according to a study that maps changes similar to those seen a decade ago when drug resistance spread in south-east Asia.

In Cambodia and neighbouring countries, the artemisinin drug compounds widely used against malaria are no longer always effective. The falciparum malaria parasites have developed genetic mutations that allow them to evade the drugs. There has been great concern that drug resistance could spread to Africa, which has the highest burden of cases of this type of malaria – and the highest toll of child deaths from it.

Continue reading...

Team behind Oxford Covid jab start final stage of malaria vaccine trials

Vaccine could be in use by 2024 if next year’s human trials are successful

The Oxford team that has produced a successful coronavirus vaccine is about to enter the final stage of human trials in its quest for an inoculation against malaria.

The Jenner Institute director, Prof Adrian Hill, said the malaria vaccine would be tested on 4,800 children in Africa next year after early trials yielded promising results.

Continue reading...

Sudan government denies Rift Valley fever outbreak despite reports of deaths

Doctors say cases and dozens of deaths from the disease have occurred since August floods, with cases of malaria and cholera also on the rise

An outbreak of Rift Valley fever has killed dozens of people and infected more than 1,000 in Sudan’s Northern state, according to local doctors.

Doctors told the Guardian the disease has spread across the towns of Merowe, Al Dabbah and Karima, mainly among cattle herders.

Continue reading...

Malaria campaigns fight off Covid disruptions to deliver programmes

Almost all planned work against the disease has gone ahead this year, delivering nets, drugs and the world’s first malaria vaccine

More than 90% of anti-malaria campaigns planned this year across four continents are on track, despite disruptions caused by the coronavirus pandemic, according to new research.

The delivery of insecticide-treated nets and provision of antimalarial medicines in the majority of malaria-affected countries across Africa, Asia and the Americas were still going ahead, a high-level meeting organised by the RBM Partnership to End Malaria heard on Thursday.

Continue reading...

Pandemic could ‘turn back the clock’ 20 years on malaria deaths, warns WHO

Deaths in sub-Saharan African countries could double to more than 700,000 this year if Covid-19 crisis disrupts programmes

Deaths from malaria could double across sub-Saharan Africa this year if work to prevent the disease is disrupted by Covid-19, the World Health Organization has warned.

The UN’s global health agency said that if countries failed to maintain delivery of insecticide-treated nets and access to antimalarial medicines, up to 769,000 people could die of malaria this year. That figure, which would be more than double the number of deaths in 2018, would mark a return to mortality levels last seen 20 years ago.

Continue reading...

‘Millions hang by a thread’: extreme global hunger compounded by Covid-19

Coronavirus ‘potentially catastrophic’ for nations already suffering food insecurity caused by famine, migration and unemployment

The warning from the World Food Programme (WFP) that an extra 265 million people could be pushed into acute food insecurity by Covid-19, almost doubling last year’s total, is based on a complex combination of factors.

WFP’s latest warning underlines the increasing concern among experts in the field that for many the biggest impact will not be the disease, but the hunger hanging off its coat tails.

Continue reading...

Zimbabwe faces malaria outbreak as it locks down to counter coronavirus

A rise in cases of the mosquito-borne disease poses another layer of threat in a country where the health system is already struggling

At least 131 people have died from malaria in Zimbabwe in a new outbreak, adding pressure to a country already struggling to deal with Covid-19.

The fatalities occurred in 201 outbreaks recorded across the country, according to the Ministry of Health. Meanwhile Zimbabwe’s lockdown has been extended by two weeks to prevent the spread of coronavirus.

Continue reading...

Wiping out the daughters: Burkina Faso’s controversial mosquito experiment

A radical experiment to genetically modify a strain of mosquito in order to stop them breeding malaria-carrying daughters is one of the latest efforts to tackle the deadly scourge of malaria

At 6.30am five-year-old Osman Balama and his mother reach the state hospital of Bobo-Dioulasso, the second-largest city in Burkina Faso. He hasn’t been feeling well for a few days and his mother is worried that he has contracted malaria. The waiting room is already full of mothers and grandmothers with young children on their laps, all with the same tired look as Osman.

“The rainy season has started,” says Sami Palm, head of the clinic. “That means more mosquitos. I’m certain that almost everyone here has malaria.”

Continue reading...

People v mosquitos: what to do about our biggest killer

These tiny pests adapt so successfully to changing conditions that they have become humankind’s deadliest predator. We might soon be able to eradicate them – but should we? By Timothy Winegard

We are at war with the mosquito. A swarming and consuming army of 110tn enemy mosquitoes patrols every inch of the globe except for Antarctica, Iceland and a handful of French Polynesian micro-islands. The biting female warrior of this droning insect population is armed with at least 15 lethal and debilitating biological weapons, to be used against 7.7 billion humans deploying suspect and often self-detrimental defensive capabilities. In fact, our defence budget for personal shields, sprays and other means of deterring her unrelenting raids is $11bn (£8.8bn) a year, and rising rapidly. And yet her deadly offensive campaigns and crimes against humanity continue with reckless abandon. While our counterattacks are reducing the number of casualties she perpetrates – malaria deaths in particular are declining rapidly – the mosquito remains the deadliest hunter of human beings on the planet.

Taking a broad range of estimates into account, since 2000, the average annual number of human deaths caused by the mosquito was around 2 million. Humans came in a distant second at 475,000, followed by snakes (50,000), dogs and sandflies (25,000 each), the tsetse fly, and the assassin or kissing bug (10,000 each). The fierce killers of lore and Hollywood celebrity were much further down our list. The crocodile was ranked 10th, with 1,000 annual deaths. Next on the list were hippos with 500, and elephants and lions with 100 fatalities each. The much-slandered shark and wolf shared 15th position, killing an average of 10 people per annum.

Continue reading...

History shows it will take more than technology and money to beat malaria

Hopes of eradicating the disease by 2050 will fail unless we tackle the poverty and weak governance that allow it to thrive

The Lancet Commission on malaria eradication received widespread attention this week with its claim that the disease could be eradicated by 2050. This would be a very welcome achievement, as malaria currently kills about 435,000 people – predominantly children – each year.

The report argues that the key to eradicating malaria is the application of existing and new technology, coupled with £1.6bn extra annual funding. Unfortunately, this solution is unlikely to be successful because it fails to address the underlying causes of malaria: grinding poverty and state incapacity.

Continue reading...

Malaria breakthrough as scientists find ‘highly effective’ way to kill parasite

Drugs derived from Ivermectin, which makes human blood deadly to mosquitoes, could be available within two years

Human trials of new antimalarial drugs are in the pipeline after Kenyan scientists successfully used bacteria to kill the parasite that causes the disease.

The Kenya Medical Research Institute (Kemri) and global health partners say the breakthrough could potentially lead to the development of a new class of drugs in less than two years.

Continue reading...

Burundi malaria outbreak at epidemic levels as half of population infected

World Health Organization records 1,800 malaria deaths since start of year, almost equalling number of lives claimed by Ebola in DRC

A serious outbreak of malaria in Burundi has reached epidemic proportions, killing almost as many people as the Ebola crisis in the nearby Democratic Republic of the Congo.

The outbreak in the tiny Great Lakes country has infected almost half the total population, killing about 1,800 people since the beginning of the year.

Continue reading...